NorA efflux pump protein (NorA)

The NorA efflux pump is a 42 kDa membrane transporter protein comprising 12 transmembrane segments, belonging to the major facilitator superfamily (MFS). Its primary role is to extrude a broad range of substrates, notably fluoroquinolone antibiotics, biocides, antiseptics, and dyes, from bacterial cells using a proton-coupled antiport mechanism with 2:1 proton:drug stoichiometry. Overexpression of NorA is common in clinical isolates of S. aureus, particularly MRSA, and is strongly associated with multidrug resistance. NorA also contributes to virulence, biofilm formation, and adaptive resistance. Efflux pump inhibitors are being developed to counteract NorA-mediated resistance, but none have reached clinical approval so far. Experimental inhibitors include synthetic peptides, Fabs, and several small molecules that block either the substrate pocket or the gene expression of NorA, restoring antibiotic efficacy. NorA is considered a high-value antimicrobial resistance target, especially as a means to restore the activity of fluoroquinolone drugs against resistant S. aureus, but clinical exploitation is still challenged by specificity, efficacy, and the rapid evolution of bacterial resistance.

Other names

Staphylococcus aureus NorANorA transporterNorA efflux transporter

Drugs (mainly fluoroquinolones and various biocides) are actively extruded from bacterial cells via a proton-coupled antiport mechanism. Inhibitors block the substrate binding site or interfere with the pump’s conformational changes, thereby preventing drug extrusion and restoring intracellular antibiotic concentrations.